Fredun Pharmaceuticals Limited, a prominent pharmaceutical formulation manufacturer in India, is expanding its manufacturing capabilities with a new 40,000 sq. ft. facility in Palghar, Maharashtra. This marks the company's fifth manufacturing site and is part of its strategic growth initiatives aimed at enhancing production efficiency and scalability. The facility is expected to be operational by October 2026 and will focus on key product categories, including veterinary products, supportive nutraceuticals, and pharmaceutical formulations. The expansion will integrate with existing facilities, reinforcing Fredun's position in the healthcare industry while ensuring high standards of quality and compliance. Managing Director Fredun Medhora emphasized the importance of this expansion in aligning with the company's growing business needs and opportunities across key segments.